Expression of C-type natriuretic peptide and of its receptor NPR-B in normal and failing heart

Peptides

Volumn 29, Issue 12, 2008, Pages 2208-2215

  Del Ry, Silvia ^a   Cabiati, Manuela ^b   Lionetti, Vincenzo ^b   Emdin, Michele ^a   Recchia, Fabio A ^b,c   Giannessi, Daniela ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b SCUOLA SUPERIORE SANT ANNA   (Italy)

^c NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

C type natriuretic peptide; Chronic heart failure; Natriuretic peptide; Natriuretic peptide receptors

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; HEART MUSCLE EXTRACT; MESSENGER RNA; NATRIURETIC PEPTIDE RECEPTOR B; NATRIURETIC PEPTIDE TYPE C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HEART ATRIUM; HEART FAILURE; HEART PACING; HEART VENTRICLE; HEMODYNAMICS; MALE; MINIPIG; NONHUMAN; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RADIOIMMUNOASSAY; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; CARDIAC PACING, ARTIFICIAL; HEART FAILURE; MALE; MYOCARDIUM; NATRIURETIC PEPTIDE, C-TYPE; RECEPTORS, ATRIAL NATRIURETIC FACTOR; SWINE; SWINE, MINIATURE;

EID: 55949127943     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2008.09.005     Document Type: Article

References (38)

1. Ahluwalia A., and Hobbs A.J. Endothelium-derived C-type natriuretic peptide: more than just a hyperpolarizing factor. Trends Pharmacol Sci 26 (2005) 162-167
2. Ahmed M.S., von Lueder T.G., Oie E., Kjekshus H., and Attramadal H. Induction of myocardial connective tissue growth factor in pacing-induced heart failure in pigs. Acta Physiol Scand 184 (2005) 27-36
3. Clerico A., and Vittorini S. The cardiac natriuretic hormone system. In: Clerico A., and Emdin M. (Eds). Natriuretic peptides: the hormones of the heart (2006), Springer-Verlag Italia, Trento, Italy 49-51
4. Davidson N.C., Barr C.S., and Struthers A.D. C-type natriuretic peptide. An endogenous inhibitor of vascular angiotensin-converting enzyme activity. Circulation 931 (1996) 155-159
5. de Bold A.J. Atrial natriuretic factor: a hormone produced by the heart. Science 230 (1985) 767-770
6. Del Ry S., Maltinti M., Emdin M., Passino C., Catapano G., and Giannessi D. Radioimmunoassay for plasma C-type natriuretic peptide determination: a methodological evaluation. Clin Chem Lab Med 43 (2005) 641-645
7. Del Ry S., Passino C., Maltinti M., Emdin M., and Giannessi D. C-type natriuretic peptide plasma levels increase in patients with congestive heart failure as a function of clinical severity. Eur J Heart Failure 7 (2005) 1145-1148
8. Del Ry S., Maltinti M., Piacenti M., Passino C., Emdin M., and Giannessi D. Cardiac production of C-type natriuretic peptide in heart failure. J Cardiovasc Med 7 6 (2006) 397-399
9. Del Ry S., Giannessi D., Maltinti M., Prontera C., Iervasi A., Colotti C., et al. C-type natriuretic peptide in patients with idiopathic left ventricular dysfunction. Peptides 28 (2007) 1068-1073
10. Del Ry S., Cabiati M., Lionetti V., Colotti C., Maltinti M., Emdin M., Recchia F., and Giannessi D. Sequencing and cardiac expression of natriuretic peptide receptor 2 (NPR-B) in Sus Scrofa. Peptides 28 (2007) 1390-1396 10.1016/j.peptides.2007.05.003
11. Del Ry S., Maltinti M., Cabiati M., Emdin M., Giannessi D., and Morales M.A. C-type natriuretic peptide and its relation to non invasive indices of left ventricular function in patients with chronic heart failure. Peptides 29 (2008) 79-82
12. Dickey D.M., Flora D.R., Bryan P.M., Xu X., Chen Y., and Potter L.R. Differential regulation of membrane guanylyl cyclases in congestive heart failure: natriuretic peptide receptor (NPR)-B, not NPR-A, is the predominant natriuretic peptide receptor in the failing heart. Endocrinology 148 (2007) 3518-3522
13. Evans J.J., Youssef A.H., and Yandle T.G. Effects of endothelin-1 on release of adrenomedullin and C-type natriuretic peptide from individual human vascular endothelial cells. J Endocrinol 175 (2002) 225-232
14. Fu X.H., Liu X.K., Gu X.S., Fan W.Z., Hao G.Z., Liu J., et al. Experimental research on establishing chronic ischemic heart failure model of minipig with intracoronary perfusion of plastic microspheres by catheterization. Zhonghua Yi Xue Za Zhi 86 (2006) 1129-1132
15. Helmer G.A., Mckirnan M.D., Shabetai R., Boss G.R., Ross Jr. J., and Hammond H.K. Regional deficits of myocardial blood flow and function in left ventricular pacing-induced heart failure. Circulation 94 (1996) 2260-2267
16. Kalra P.R., Clague J.R., Bolger A.P., Anker S.D., Poole-Wilson P.A., Struthers A.D., et al. Myocardial production of C-type natriuretic peptide in chronic heart failure. Circulation 107 (2003) 571-573
17. Klinge R., Hystad M., Kjekshus J., Karberg B.E., Djoseland O., Aakvaag A., et al. An experimental study of cardiac natriuretic peptidesas markers of development of congestive heart failure. Scand J Clin Lab Invest 58 8 (1998) 683-691
18. Kohno M., Horio T., and yokokawa K. C-type natriuretic peptide inhibits thrombin- and angiotensin II-stimulated endothelin release via cyclic guanosine 3′, 5′-monophoshate. Hypertension 19 (1992) 320-325
19. Koller K.J., Love D.G., Bennett G.L., Minamino N., Kangawa K., Matsuo H., et al. Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science 252 (2006) 120-123
20. Langenickel I.P., Buttgereit J., Bader M., and Langenickel T.H. Natriuretic peptide receptor B signaling in the cardiovascular system: protection from cardiac hypertrophy. J Mol Med 85 (2007) 797-810
21. Levin E.R., Gardner D.G., and Samson W.K. Natriuretic peptides. N Engl J Med 339 (1998) 321-328
22. Lionetti V., Guiducci L., Simioniuc A., Aquaro D.G., Simi C., De Marchi D., et al. Mismatch between uniform increase in cardiac glucose uptake and regional contractile dysfunction in pacing-induced heart failure. Am J Physiol Heart Circ Physiol 293 (2007) H2747-H2756
23. Lowry O.H., Rosebrough A., Farr A., and Randall R.J. Protein measurement with the folin phenol reagent. J Biol Chem 193 (1951) 265-267
24. Luchner A., Stevens T.L., Borgeson D.D., Redfield M., Wei C.M., Porter J.G., and Burnett Jr. J.C. Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure. Am J Physiol 274 (1998) H1684-H1689
25. Nazario B., Hu R., Pedram A., Bruce P., and Levin E.R. Atrial and brain natriuretic peptides stimulate the production and secretion of C-type natriuretic peptide from bovine aortic endothelial cells. J Clin Invest 95 (1995) 1151-1157
26. Pemberton C.J., Yandle T.G., Charles C.J., Rademaker M.T., Aitken G.D., and Espiner E.A. Ovine brain natriuretic peptide in cardiac tissues and plasma: effects of cardiac hypertrophy and heart failure on tissue concentration and molecular forms. J Endocrinol 155 (1997) 541-550
27. Pilo A., Zucchelli G.C., Malvano R., and Masini S. Main features of computer algorithms for RIA data reduction. Comparison of same different approaches for the interpolation of dose-response curve. J Nucl Med All Sci 26 (1982) 235-248
28. Potter L.R., Abbey-Hosch S., and Dickey D.M. Natriuretic peptides, their receptors and cGMP-dependent signaling functions. Endocr Rev 27 (2005) 47-72
29. Qi W., Kjekshus H., Klinge R., Kjekshus J.K., and Hall C. Cardiac natriuretic peptides and continuously monitored atrial pressures during chronic rapid pacing in pigs. Acta Physiol Scand 169 (2000) 95-102
30. Schiffrin E. Decreased density of binding sites for atrial natriutic peptide on platelets of patients congestive cardiomyopathy. Eur J Clin Invest 18 (1988) 524-528
31. Soeki T., Kishimoto I., Okumura H., Tokudome T., Horio T., Mori K., et al. C-type natriuretic peptide, a novel antifibrotic and antihypertropic agent, prevents cardiac remodeling after myocardial infarction. J Am Coll Cardiol 45 (2005) 608-616
32. Spragg D.D., Leclercq C., Loghmani M., Faris O.P., Tunin R.S., DiSilvestre D., et al. Regional alterations in protein expression in the dyssynchronous failing heart. Circulation 108 (2003) 929-932
33. Sudoh T., Kangawa K., Minamino N., and Matsuo H. A new natriuretic peptide in porcine brain. Nature 332 (1988) 78-81
34. Sudoh T., Minamino N., Kangawa K., and Matsuo H. C-type natriuretic peptide (CNP): a new member of the natriuretic peptide family identified in porcine brain. Biochem Biopys Res Commun 168 (1990) 863-870
35. Suga S., Nakao K., Hosoda K., Mukoyama M., Ogawa Y., Shirakami G., et al. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic. Endocrinology 130 (1992) 229-239
36. Tsutamoto T., Kanamory T., Morigami N., Sugimoto Y., Yamaoka O., and Kinoshita M. Possibility of downregulation of atrial natriuretic peptide receptor coupled to guanylate cyclase in peripheral vascular beds of patients with chronic severe heart failure. Circulation 87 (1993) 70-75
37. Tusnoda K., Mendelsoohm F.A.O., sexton P.M., Chai S.Y., Hodsman G.P., and Johnston C.I. Decreased atrial natriuretic peptide binding in renal medulla in rats with chronic heart failure failure. Circ Res 62 (1988) 155-161
38. Zolk O., Quattek J., Sitzler G., Schrader T., Nickenig G., Schnabel P., Shimada K., Takahashi M., and Bohm M. Expression of endothelin-1, endothelin convertine enzyme, and endothelin receptors in chronic heart failure. Circulation 99 (1999) 2118-2123